Literature DB >> 9884344

Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.

D Fatkin1, M E Christe, O Aristizabal, B K McConnell, S Srinivasan, F J Schoen, C E Seidman, D H Turnbull, J G Seidman.   

Abstract

Heterozygous mice bearing an Arg403Gln missense mutation in the alpha cardiac myosin heavy chain gene (alpha-MHC403/+) exhibit the histopathologic features of human familial hypertrophic cardiomyopathy. Surprisingly, homozygous alpha-MHC403/403 mice die by postnatal day 8. Here we report that neonatal lethality is caused by a fulminant dilated cardiomyopathy characterized by myocyte dysfunction and loss. Heart tissues from neonatal wild-type and alpha-MHC403/403 mice demonstrate equivalent switching of MHC isoforms; alpha isoforms in each increase from 30% at birth to 70% by day 6. Cardiac dimensions and function, studied for the first time in neonatal mice by high frequency (45 MHz) echocardiography, were normal at birth. Between days 4 and 6, alpha-MHC403/403 mice developed a rapidly progressive cardiomyopathy with left ventricular dilation, wall thinning, and reduced systolic contraction. Histopathology revealed myocardial necrosis with dystrophic calcification. Electron microscopy showed normal architecture intermixed with focal myofibrillar disarray. We conclude that 45-MHz echocardiography is an excellent tool for assessing cardiac physiology in neonatal mice and that the concentration of Gln403 alpha cardiac MHC in myocytes influences both cell function and cell viability. We speculate that variable incorporation of mutant and normal MHC into sarcomeres of heterozygotes may account for focal myocyte death in familial hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9884344      PMCID: PMC407864          DOI: 10.1172/JCI4631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia.

Authors:  P Anversa; J Kajstura; K Reiss; F Quaini; A Baldini; G Olivetti; E H Sonnenblick
Journal:  Ann N Y Acad Sci       Date:  1995-03-27       Impact factor: 5.691

2.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

Authors:  E B Lankford; N D Epstein; L Fananapazir; H L Sweeney
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

4.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.

Authors:  H L Sweeney; A J Straceski; L A Leinwand; B A Tikunov; L Faust
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

5.  Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation.

Authors:  O Parodi; R De Maria; L Oltrona; R Testa; G Sambuceti; A Roghi; M Merli; L Belingheri; R Accinni; F Spinelli
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

6.  Echocardiographic evaluation of size, function, and mass of normal and hypertrophied rat ventricles.

Authors:  D G Pawlush; R L Moore; T I Musch; W R Davidson
Journal:  J Appl Physiol (1985)       Date:  1993-05

7.  Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice.

Authors:  G W Dorn; J Robbins; N Ball; R A Walsh
Journal:  Am J Physiol       Date:  1994-07

8.  Structure of the actin-myosin complex and its implications for muscle contraction.

Authors:  I Rayment; H M Holden; M Whittaker; C B Yohn; M Lorenz; K C Holmes; R A Milligan
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

9.  Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; W S Zhu; J R Sellers; N D Epstein
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy.

Authors:  H Nishi; A Kimura; H Harada; K Adachi; Y Koga; T Sasazuki; H Toshima
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

View more
  30 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

Review 2.  Role of animal models in HCM research.

Authors:  Rhian Shephard; Christopher Semsarian
Journal:  J Cardiovasc Transl Res       Date:  2009-08-07       Impact factor: 4.132

3.  Overproduction of cardiac S-adenosylmethionine decarboxylase in transgenic mice.

Authors:  Oleg Nisenberg; Anthony E Pegg; Patricia A Welsh; Kerry Keefer; Lisa M Shantz
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  An evaluation of transmitral and pulmonary venous Doppler indices for assessing murine left ventricular diastolic function.

Authors:  Lijun Yuan; Tao Wang; Fang Liu; Ethan D Cohen; Vickas V Patel
Journal:  J Am Soc Echocardiogr       Date:  2010-06-29       Impact factor: 5.251

5.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

Authors:  B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Calcification of myocardial necrosis is common in mice.

Authors:  Susanne Korff; Nora Riechert; Frank Schoensiegel; Dieter Weichenhan; Frank Autschbach; Hugo Albert Katus; Boris Tomislav Ivandic
Journal:  Virchows Arch       Date:  2005-10-07       Impact factor: 4.064

Review 7.  Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.

Authors:  A J Marian; L Salek; S Lutucuta
Journal:  Minerva Med       Date:  2001-12       Impact factor: 4.806

8.  Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart.

Authors:  Kyriakos N Papanicolaou; Ryosuke Kikuchi; Gladys A Ngoh; Kimberly A Coughlan; Isabel Dominguez; William C Stanley; Kenneth Walsh
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

9.  The cardiac L-type calcium channel distal carboxy terminus autoinhibition is regulated by calcium.

Authors:  Shawn M Crump; Douglas A Andres; Gail Sievert; Jonathan Satin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

10.  Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy.

Authors:  Kalliopi Pilichou; Carol Ann Remme; Cristina Basso; Maria E Campian; Stefania Rizzo; Phil Barnett; Brendon P Scicluna; Barbara Bauce; Maurice J B van den Hoff; Jacques M T de Bakker; Hanno L Tan; Marialuisa Valente; Andrea Nava; Arthur A M Wilde; Antoon F M Moorman; Gaetano Thiene; Connie R Bezzina
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.